Meister, J., Bone, D. B. J., Knudsen, J. R., Barella, L. F., Velenosi, T. J., Akhmedov, D., Lee, R. J., Cohen, A. H., Gavrilova, O., Cui, Y., Karsenty, G., Chen, M., Weinstein, L. S., Kleinert, M., Berdeaux, R., Jensen, T. E., Richter, E. A., & Wess, J. (2022). Clenbuterol exerts antidiabetic activity through metabolic reprogramming of skeletal muscle cells. Nature Communications, 13(1). https://doi.org/10.1038/s41467-021-27540-w
Subjects:
Cellular Reprogramming
(MeSH)
Clenbuterol
(MeSH)
Hypoglycemic Agents
(MeSH)
Muscle Fibers, Skeletal
(MeSH)
Muscle, Skeletal
(MeSH)
Publication Type:
Article
Unique ID:
10.1038/s41467-021-27540-w
PMID:
Journal:
Publication Date:
Data Source:
Scopus